DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes

Author： Tuccinardi Dario   Fioriti Elvira   Manfrini Silvia   D'Amico Eugenio   Pozzilli Paolo  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.11, Iss.9, 2011-09, pp. : 1233-1240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes – an update

By Fischer Britta   Elias Dana   Bretzel Reinhard G   Linn Thomas  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 2, 2010-02 ,pp. : 265-272

Informa Healthcare

Access to resources Recommend Favorite

Immune and cell therapy in type 1 diabetes: too little too late?

By Gillard Pieter   Mathieu Chantal  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 5, 2011-05 ,pp. : 609-621

Informa Healthcare

Access to resources Recommend Favorite

Teplizumab therapy for type 1 diabetes

By Masharani Umesh B   Becker Joseph  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 459-465

Informa Healthcare

Access to resources Recommend Favorite

Roles of cytokines in the pathogenesis and therapy of type 1 diabetes

By Rabinovitch Alex   Suarez-Pinzon Wilma  

Cell Biochemistry and Biophysics, Vol. 48, Iss. 2-3, 2007-07 ,pp. : 159-163

Humana Press, Inc

Access to resources Recommend Favorite

Treatment of diabetes with glucagon-like peptide-1 gene therapy

By Riedel Michael J   Kieffer Timothy J  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 12, 2010-12 ,pp. : 1681-1692

Informa Healthcare

Access to resources Recommend Favorite